Why the study?
Given the complexity of cardiac genetics, including epigenetic factors, environmental factors, incomplete penetrance, and variable expressivity, practical guidance on genetic testing for cardiomyopathies and channelopathies is needed.
Genetic testing is indicated in patients with a strong suspicion of an inheritable cardiac disorder after full clinical evaluation, aiding in diagnosis, prognostication, and cascade testing.
Supports targeted testing in high-suspicion cases; leaves open optimal yield, cost-effectiveness, and broader screening strategies.
Genetic testing has an increasingly important role in the diagnosis and management of cardiac disorders, where it confirms the diagnosis, aids prognostication and risk stratification and guides treatment. A genetic diagnosis in the proband also enables clarification of the risk for family members by cascade testing. Genetics in cardiac disorders is complex where epigenetic and environmental factors might come into interplay. Incomplete penetrance and variable expressivity is also common. Genetic results in cardiac conditions are mostly probabilistic and should be interpreted with all available clinical information. With this complexity in cardiac genetics, testing is only indicated in patients with a strong suspicion of an inheritable cardiac disorder after a full clinical evaluation. In this review we discuss the genetics underlying the major cardiomyopathies and channelopathies, and the practical aspects of diagnosing these conditions in the laboratory.
No takes yet. Share an insight, caveat, or question.
Han‐Chih Hencher Lee (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: